STERIS plc (NYSE:STE) Shares Bought by American International Group Inc.

American International Group Inc. grew its holdings in shares of STERIS plc (NYSE:STE) by 1.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,574 shares of the medical equipment provider’s stock after purchasing an additional 466 shares during the period. American International Group Inc.’s holdings in STERIS were worth $5,842,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of STE. Fenimore Asset Management Inc. grew its holdings in STERIS by 13.1% during the fourth quarter. Fenimore Asset Management Inc. now owns 210,747 shares of the medical equipment provider’s stock worth $46,333,000 after acquiring an additional 24,377 shares during the period. Caden Capital Partners LP grew its holdings in STERIS by 80.0% during the fourth quarter. Caden Capital Partners LP now owns 82,312 shares of the medical equipment provider’s stock worth $18,096,000 after acquiring an additional 36,576 shares during the period. Cullen Investment Group LTD. acquired a new position in STERIS during the fourth quarter worth about $1,351,000. Cerity Partners LLC grew its holdings in STERIS by 5,199.4% during the fourth quarter. Cerity Partners LLC now owns 65,925 shares of the medical equipment provider’s stock worth $14,494,000 after acquiring an additional 64,681 shares during the period. Finally, Financiere des Professionnels Fonds d investissement inc. grew its holdings in STERIS by 12.9% during the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 45,095 shares of the medical equipment provider’s stock worth $9,914,000 after acquiring an additional 5,168 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Activity at STERIS

In related news, SVP Cary L. Majors sold 2,024 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares of the company’s stock, valued at approximately $2,639,085.97. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, Director Jacqueline B. Kosecoff sold 4,584 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $231.53, for a total value of $1,061,333.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Cary L. Majors sold 2,024 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares of the company’s stock, valued at $2,639,085.97. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,762 shares of company stock valued at $1,798,477. 1.14% of the stock is owned by corporate insiders.

STERIS Trading Down 0.4 %

Shares of NYSE STE opened at $218.41 on Friday. STERIS plc has a one year low of $195.47 and a one year high of $254.00. The firm has a market capitalization of $21.59 billion, a PE ratio of 57.18 and a beta of 0.85. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average price of $218.42 and a two-hundred day moving average price of $220.38.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period last year, the company posted $2.30 EPS. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. As a group, analysts predict that STERIS plc will post 9.24 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, June 12th. This represents a $2.08 annualized dividend and a dividend yield of 0.95%. STERIS’s payout ratio is 54.45%.

Wall Street Analyst Weigh In

STE has been the subject of a number of recent analyst reports. StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Saturday, June 15th. Piper Sandler reiterated a “neutral” rating and issued a $225.00 price target (up previously from $220.00) on shares of STERIS in a research report on Friday, May 10th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, May 9th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, May 10th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $241.60.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.